Fitness for 5 genes in Bacteroides thetaiotaomicron VPI-5482

Add gene:

Number of genes on each side:  

Top 30 experiments (either direction), sorted by average fitness

Or view all 868 experiments or choose conditions or try the comparative fitness browser

500 ntBT3033 and BT3034 overlap by 4 nucleotidesBT3034 and BT3035 are separated by 105 nucleotidesBT3035 and BT3036 are separated by 80 nucleotidesBT3036 and BT3037 are separated by 207 nucleotides BT3033: BT3033 - DNA topoisomerase IV subunit B (NCBI ptt file), at 3,840,014 to 3,841,891 BT3033 BT3034: BT3034 - phosphopantetheine adenylyltransferase (NCBI ptt file), at 3,841,888 to 3,842,343 BT3034 BT3035: BT3035 - carboxy-terminal processing protease precursor (NCBI ptt file), at 3,842,449 to 3,844,038 BT3035 BT3036: BT3036 - conserved hypothetical protein (NCBI ptt file), at 3,844,119 to 3,846,701 BT3036 BT3037: BT3037 - RNA polymerase ECF-type sigma factor (NCBI ptt file), at 3,846,909 to 3,847,418 BT3037
Group Condition BT3033 BT3034 BT3035 BT3036 BT3037
stress Varel_Bryant_medium_Glucose with Deoxycholic 0.075 mg/ml N.D. N.D. -4.5 -0.0 +0.5
stress Varel_Bryant_medium_Glucose with Geneticin G418 0.2 mM N.D. N.D. -3.3 -0.1 -0.6
nitrogen source L-aspartic (N) N.D. N.D. -3.2 -0.2 -0.5
stress Varel_Bryant_medium_Glucose with Deoxycholic 0.075 mg/ml N.D. N.D. -3.8 -0.1 +0.3
nitrogen source L-Glutamine (N) N.D. N.D. -3.2 -0.1 -0.3
stress Varel_Bryant_medium_Glucose with Lithocholic 0.2 mg/ml N.D. N.D. -3.7 -0.1 +0.2
stress Varel_Bryant_medium_Glucose with Chenodeoxycholic 0.5 mg/ml N.D. N.D. -3.6 -0.1 +0.3
stress Varel_Bryant_medium_Glucose with Chenodeoxycholic 0.25 mg/ml N.D. N.D. -3.6 +0.0 +0.2
nitrogen source L-Asparagine (N); Varel_Bryant_medium_Glucose_lowCys_noNitrogen N.D. N.D. -3.2 +0.1 -0.3
stress Varel_Bryant_medium_Glucose with Ciprofloxacin Hydrochloride 0.025 mM N.D. N.D. -3.0 -0.2 -0.1
stress Varel_Bryant medium with Irgasan 0.0025 mM N.D. N.D. -2.6 -0.1 -0.5
stress Nickel (II) chloride 0.01 mM N.D. N.D. -2.5 +0.0 -0.6
stress Varel_Bryant medium with Chlorpromazine 0.05 mM N.D. N.D. -3.0 +0.1 -0.1
nitrogen source L-Valine (N) N.D. N.D. -2.1 -0.0 -1.0
stress Varel_Bryant medium with Chlorhexidine diacetate salt 0.00075 mM N.D. N.D. -2.8 -0.0 -0.3
stress Varel_Bryant medium with Chlorhexidine diacetate salt 0.0015 mM N.D. N.D. -2.5 +0.0 -0.5
stress Varel_Bryant medium with Irgasan 0.005 mM N.D. N.D. -2.7 +0.1 -0.3
stress Varel_Bryant_medium_Glucose with Chenodeoxycholic 0.125 mg/ml N.D. N.D. -3.0 -0.0 +0.2
stress Varel_Bryant_medium_Glucose with Deoxycholic 0.2 mg/ml N.D. N.D. -3.1 -0.2 +0.5
stress Bile salts 0.25 mg/ml N.D. N.D. -2.9 +0.1 +0.1
stress Varel_Bryant_medium_Glucose with Deoxycholic 0.1 mg/ml N.D. N.D. -3.0 -0.1 +0.5
nitrogen source L-Asparagine (N); Varel_Bryant_medium_Glucose_lowCys_noNitrogen N.D. N.D. -3.1 -0.0 +0.7
carbon source D-Glucose 5 mg/ml (C) N.D. N.D. -2.8 -0.2 +0.6
stress Varel_Bryant_medium_Glucose with Deoxycholic 0.2 mg/ml N.D. N.D. -3.0 +0.1 +0.5
stress Bile salts 0.5 mg/ml N.D. N.D. -3.1 +0.2 +0.7
nitrogen source Ammonium chloride (N); Varel_Bryant_medium_Glucose_lowCys_noNitrogen N.D. N.D. -2.9 +0.0 +0.8
nitrogen source L-Asparagine (N); Varel_Bryant_medium_Glucose_noMET_DTT_NaS_B12_noNitrogen N.D. N.D. -2.3 -0.2 +0.6
stress Bile salts 0.5 mg/ml N.D. N.D. -2.7 +0.1 +0.8
nitrogen source L-Glutamine (N); Varel_Bryant_medium_Glucose_noMET_DTT_NaS_B12_noNitrogen N.D. N.D. -2.4 +0.1 +0.5
nitrogen source L-Asparagine (N); Varel_Bryant_medium_Glucose_noMET_DTT_NaS_B12_noNitrogen N.D. N.D. -2.4 -0.1 +0.8
remove
BT3033
plot		 remove
BT3034
plot		 remove
BT3035		 remove
BT3036
plot		 remove
BT3037
plot